With generic prescriptions accounting for 90% of prescriptions filled but only 17.5% of prescription drug spend (2023 U.S
I am currently taking both medicationswhat should I do
Some research However, a new study, published in Diabetes, Obesity and Metabolism, indicates that people may maintain much of their weight loss after discontinuation, particularly if they transition to other treatments or lifestyle support
Low Side Effect Profile: Demonstrates minimal interaction with non-target endocrine pathways in laboratory settings
Research on phentermine suggests 5% is the upper limit for weight loss, and since its a short-term medication, it does not help you maintain weight loss over the long term
Theres a considerable, unmet need around the treatment of MASH given rising cases and since resmetirom (Rezdiffra) is the only FDA-approved drug for this condition